Hammersmith Medicines Research Ltd Email Format

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

Hammersmith Medicines Research Ltd is a contract research organization based in London, specializing in early-stage clinical testing with a focus on phase 1 and early phase 2 studies. The facility supports those trials with 145 patient beds, a sleep unit for polysomnography, volunteer accommodations, in-house laboratories, a pharmacy with an aseptic unit and radiopharmacy, and office space. The organization has a multidisciplinary staff and has completed more than 850 studies since 1993, making it one of Europe’s larger early-phase CROs. 

The company serves sponsors and research partners seeking comprehensive early-phase trial services, offering a full-service CRO capable of managing the clinical, laboratory, and volunteer aspects of studies. In August 2025, Nucleus Network announced its acquisition of Hammersmith Medicines Research Ltd.

Sign up for free to view info

Company overview Employee directory